- New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis
-
Woo HY, Heo J
- KMID: 2164360
- Clin Mol Hepatol.
- 2015 Jun;21(2):115-121.
- doi: 10.3350/cmh.2015.21.2.115
Despite advances in the treatment of hepatocellular carcinoma (HCC), managing HCC with portal vein thrombosis (PVT) remains challenging. PVT is present in 10-40% of HCC cases at the time of... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
-
Cha J, Seong J, Lee IJ, Kim JW, Han KH
- KMID: 1793165
- Yonsei Med J.
- 2013 Sep;54(5):1178-1185.
- doi: 10.3349/ymj.2013.54.5.1178
PURPOSE: Sorafenib is an effective systemic agent for advanced hepatocellular carcinoma. To increase its efficacy, we evaluated the feasibility and benefit of sorafenib combined with radiotherapy. MATERIALS AND METHODS: From July... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends and Patterns of Hepatocellular Carcinoma Treatment in Korea
-
Hong YM, Yoon KT, Cho M, Kang DH, Kim HW, Choi CW, Park SB, Heo J, Woo HY, Lim W
- KMID: 2363501
- J Korean Med Sci.
- 2016 Mar;31(3):403-409.
- doi: 10.3346/jkms.2016.31.3.403
Multiple therapeutic modalities are available for hepatocellular carcinoma (HCC) treatment. We aimed to evaluate the trends for HCC treatment in Korea. Recent trends and patterns in treatment modalities were assessed... -
- CITED
-
- Close
- SHARE
-
- Close
